Molecular Neurodegeneration

Parkinson’s-linked mutation raises cell stress with age in mice

Brain-slice experiments in genetically engineered mice found progressively greater stress in the energy-producing structures of dopamine-producing nerve cells.

Paper by Yuanxin Chen, Lianteng Zhi, Shiquan Cui, +2 more authorsHui Zhang · Thomas Jefferson University

Our read

Mechanisms
Studied:
Experiments in mice overexpressing human LRRK2-R1441G
What changed:
Mitochondrial oxidative stress in dopamine neurons increased progressively in BAC-hR1441G mice at 3, 6, and 10 months of age
The catch:
Mitochondrial stress was measured; dopamine neuron loss and motor symptoms were not
In the record:
One of 77 papers on LRRK2 on record: 10 with results in people, 21 in animals.
Why it’s aging research:
It looks at how biology varies with age or lifespan.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

In an animal experiment, mice engineered to overproduce a mutated human protein linked to Parkinson’s disease showed rising oxidative stress in dopamine-producing nerve cells with age. Oxidative stress is an imbalance involving reactive molecules that can damage cells. Researchers examined brain slices to measure this stress in mitochondria, the cells’ energy-producing structures.

Stress increased progressively in nerve cells in the substantia nigra, a midbrain region affected by Parkinson’s disease. In separate tests of slices from the striatum, another brain region, 10-month-old mutant mice had reduced energy production and respiratory capacity compared with controls. Researchers found no significant differences in those measures at three or six months.

Why it matters

The work addresses how a Parkinson’s-linked mutation affects nerve-cell energy systems as animals age. The authors suggest that proteins controlling calcium movement and mitochondrial function could offer targets for slowing the disease’s progression.

Caveats

These experiments used mice engineered to overproduce a mutant human protein, not people with Parkinson’s disease. The abstract lists imaging at 3, 6 and 10 months, while the results excerpt lists 3, 6 and 12 months.

Comments

Be the first to comment.